-
Je něco špatně v tomto záznamu ?
Gut Microbiota as the Link between Elevated BCAA Serum Levels and Insulin Resistance
J. Gojda, M. Cahova
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
NLK
Directory of Open Access Journals
od 2011
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
PubMed
34680047
DOI
10.3390/biom11101414
Knihovny.cz E-zdroje
- MeSH
- diabetes mellitus 2. typu krev genetika MeSH
- inzulinová rezistence genetika MeSH
- krevní glukóza genetika MeSH
- lidé MeSH
- obezita krev genetika MeSH
- střevní mikroflóra genetika MeSH
- symbióza genetika MeSH
- větvené aminokyseliny krev genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
The microbiota-harboring human gut is an exquisitely active ecosystem that has evolved in a constant symbiosis with the human host. It produces numerous compounds depending on its metabolic capacity and substrates availability. Diet is the major source of the substrates that are metabolized to end-products, further serving as signal molecules in the microbiota-host cross-talk. Among these signal molecules, branched-chain amino acids (BCAAs) has gained significant scientific attention. BCAAs are abundant in animal-based dietary sources; they are both produced and degraded by gut microbiota and the host circulating levels are associated with the risk of type 2 diabetes. This review aims to summarize the current knowledge on the complex relationship between gut microbiota and its functional capacity to handle BCAAs as well as the host BCAA metabolism in insulin resistance development. Targeting gut microbiota BCAA metabolism with a dietary modulation could represent a promising approach in the prevention and treatment of insulin resistance related states, such as obesity and diabetes.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22012189
- 003
- CZ-PrNML
- 005
- 20220506131321.0
- 007
- ta
- 008
- 220425s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/biom11101414 $2 doi
- 035 __
- $a (PubMed)34680047
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Gojda, Jan $u Department of Internal Medicine, Kralovske Vinohrady University Hospital and Third Faculty of Medicine, Charles University, 10000 Prague, Czech Republic $1 https://orcid.org/0000000279955947
- 245 10
- $a Gut Microbiota as the Link between Elevated BCAA Serum Levels and Insulin Resistance / $c J. Gojda, M. Cahova
- 520 9_
- $a The microbiota-harboring human gut is an exquisitely active ecosystem that has evolved in a constant symbiosis with the human host. It produces numerous compounds depending on its metabolic capacity and substrates availability. Diet is the major source of the substrates that are metabolized to end-products, further serving as signal molecules in the microbiota-host cross-talk. Among these signal molecules, branched-chain amino acids (BCAAs) has gained significant scientific attention. BCAAs are abundant in animal-based dietary sources; they are both produced and degraded by gut microbiota and the host circulating levels are associated with the risk of type 2 diabetes. This review aims to summarize the current knowledge on the complex relationship between gut microbiota and its functional capacity to handle BCAAs as well as the host BCAA metabolism in insulin resistance development. Targeting gut microbiota BCAA metabolism with a dietary modulation could represent a promising approach in the prevention and treatment of insulin resistance related states, such as obesity and diabetes.
- 650 _2
- $a větvené aminokyseliny $x krev $x genetika $7 D000597
- 650 _2
- $a krevní glukóza $x genetika $7 D001786
- 650 _2
- $a diabetes mellitus 2. typu $x krev $x genetika $7 D003924
- 650 _2
- $a střevní mikroflóra $x genetika $7 D000069196
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inzulinová rezistence $x genetika $7 D007333
- 650 _2
- $a obezita $x krev $x genetika $7 D009765
- 650 _2
- $a symbióza $x genetika $7 D013559
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Cahova, Monika $u Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic
- 773 0_
- $w MED00188737 $t Biomolecules $x 2218-273X $g Roč. 11, č. 10 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34680047 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506131313 $b ABA008
- 999 __
- $a ok $b bmc $g 1789682 $s 1163390
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 11 $c 10 $e 20210928 $i 2218-273X $m Biomolecules $n Biomolecules $x MED00188737
- LZP __
- $a Pubmed-20220425